DrugDoses
59
Quality Score
Solid
DrugDoses
Low confidence
✍️ bumetric analysis
“
DrugDoses is an iOS app from Oliver Karam in the Education category, currently rated 4.6★ across 35 ratings. Initial signal reads as mostly critical sentiment so far: users flag rough edges and unmet expectations.
Quality Score is 59: Solid (established niche player). For a Education app, that means established niche player. The full BU Investment Matrix below scores 8 dimensions including monetisation, growth, and operational risk.
Track changes month-over-month in the Performance section below: live snapshot history and revenue forecast included.
💰 Monthly revenue · now vs forecast
● Right now
$3.9K
per month
→
12-mo forecast
$3.4K – $12.2K
per month
→
24-mo forecast
$3.1K – $28.3K
per month
INDIE tier
💡 Grow this revenue
Free AI audit of this app’s store listing
- Title & subtitle keyword fit
- Description hook & conversion structure
- Screenshots, ratings, reviews strategy
Typical impact: +2-5× organic installs
📊 Performance Tracking LIVE
Loading…
Rating
—
Reviews
—
Forecast Revenue / mo
—
Snapshots tracked
0
since first record
ONE-TIME · BUILD
💰 Estimated build cost
$60K
↳ What it cost to build · not monthly revenue
Likely range $45K – $80K
$25K · MVP floor
$100K · indie scale
$500K+ · studio build
📈
Pays back in ~6 months at current MRR
Synthetic estimate. Inputs: category complexity, file size, screen count, monetization layer, platform reach, age × team-size proxy. Calibrated against 2024-2026 indie-agency rate surveys. Full math + source list on /methodology.
Where the money goes
| 🧱 MVP baseline (design + 1-store ship) | +$28K |
| 📱 5 unique screens × $4.5K | +$22K |
| ⚙ Education complexity ×1.20 | +$10K |
Total estimate
$60K
ONE-TIME · EXIT VALUE
💵 Estimated acquisition value
$150K
↳ What it would sell for · not monthly revenue
Marketplace range $100K – $200K · 16× MRR multiple
💸
~2.5× return on build cost
Synthetic estimate. Multiple band derived from ad-supported + age, rating quality, category demand, and user-base maturity. Calibrated against 2024-2026 indie-app-marketplace closed-deal medians. Full math + comparable deal list on /methodology.
How the multiple was built
| 📺 Ad-supported base | 15× MRR |
| ⭐ ★ rating ≥ 4.4 (solid) | +8% |
| 🏷 Education category multiple | +6% |
| ⭐ Small user base (<1K ratings) | -8% |
Final multiple
16× MRR
🔬
How we forecast this revenue
MEDIUM CONFIDENCEBaseline
$3.9K/mo · ML-estimated from 234 triggers
Growth rate
+6.0% MoM · INDIE tier baseline (compound monthly)
Direction
Headwinds: rating drift may slow acquisition
6 months
$3.3K – $7.7K
12 months
$3.4K – $12.2K
24 months
$3.1K – $28.3K
Compound growth at +6.0% MoM (tier baseline for INDIE). Range widens with horizon — typical noise band ±40% at 6mo.. Ranges widen with horizon — distant futures carry more uncertainty.
📊
BU Investment Matrix
Early-stage solo · 42/100INDIE TIERexpected for tierRevenue Strength
3.6
Product Quality
3.7
Market Position
1.8
Growth Velocity
5.0
Defensibility
4.5
Operational Safety
9.0
Founder Strength
5.0
Monetization Maturity
1.0
- 💰 Revenue: Modest — $1K - $9K/mo · INDIE tier · medium confidence, trajectory unclear.
- ⭐ Quality: 4.6★ across 35 reviews — weak — significant quality concerns.
- 📍 Market: Not yet charting in any of the 9 monitored markets.
- 📈 Growth: last update 354d ago — slow cadence.
- ⚠️ Risk: Low — no material risk signals detected.
🎯 For competitors: Mixed picture. Worth competing if you have a clear UX or pricing edge — otherwise crowded segment.
💵 For acquirers: Estimated asking range 18-32× monthly = $69K-$124K. Portfolio play ($9K/mo combined) commands premium.
Composite of 8 dimensions computed deterministically from public signals — no LLM, every score traces back to a measurable input. Default weights shown; "compete" / "acquire" / "invest" lenses re-weight without re-fetching.
Range:
💰 Forecast Revenue / mo
MODELRevenue forecast computed from BU's 234 trigger model on each snapshot. Calibrated against ground-truth from 58 verified-revenue apps.
🔬Forecast Breakdown — Why This Estimate?Top 6 of 6 triggers
Our ML model uses 200+ signals from public data. These are the most influential for this app:
| Paid app ($0.00)METRIC | +$2,800 | |
| Excellent rating (4.6★)METRIC | +$2,200 | |
| Mature app (16y old)METRIC | +$1,500 | |
| highly recommendREVIEW | +$1,400 | |
| Single-language (English only)METRIC | −$400 | |
| Pre-traction phase (35 ratings)METRIC | −$300 |
METRIC = structural app data · REVIEW = mined from user reviews · ✓ VERIFIED = Stripe-verified anchor (TrustMRR)
📈 Reviews Growth
LIVECumulative review count from first BU snapshot. Each point = a tracked update.
⭐ Rating Trend
LIVEAverage rating evolution. Updates with each new review batch.
🆕 What's New · v6.7.2
This update contains the latest version of Frank Shann's dataset.
Profile & Insights
Everything we know — and don't — about this app and its company.
Identification
- App name
- DrugDoses
- Developer
- Oliver Karam
- Bundle ID
- net.drugdoses.DrugDoses
- App Store URL
- Open in App Store
- Category
- Education
- Content rating
- 17+
- Languages
- EN
Company
- Website
- Not found
- Tagline
- DrugDoses.net
- Description
- DrugDoses; Medical; Critical; Care; Intensive; PICU; Pediatric; Children; Child; Dose; Medication; App; iOS; Android; Apple; Google; Frank; Shann; Oliver; Karam
- Founded
- Not found
- HQ / Address
- Not found
- Employees
- Not found
- Logo
- Not found
Revenue
- Verified revenue / mo
- Not found
- AI revenue estimate / mo
- Not found
- AI annual estimate
- Not found
- ML model estimate / mo
- $9.3K/mo
- Top-grossing rank
- Outside top 100 in US Education
- All-time revenue
- Not found
- Pricing
- Not found
Founder
Founder data not yet collected for this app.
Funding
Funding data not yet collected for this app.
Press & Links
Press & Links data not yet collected for this app.
Contacts & Socials
- Socials
- Not found
- orders@drugdoses.com
- Phone
- Not found
- Contact page
- drugdoses.net/contact-form
- About page
- Not found
📈Ratings growth35 ratings+3400% lifetimeShow 3-year history estimate ▾
Tracked (8 weeks) Pre-tracking estimate (37 weeks) · model-based, ±5% noise · anchored to release date and current value
🌍Geographic ReachNot ranked
This app is currently outside the top 100 grossing in all 9 countries we monitor (US, UK, DE, FR, JP, CA, AU, BR, IN). Niche or new apps often launch this way — popularity rankings appear once daily revenue clears the regional threshold.
💰Pricing History$0.00 → $14.99 (+0%)
Profile is built from iTunes Lookup + developer site scrape + ML revenue model. Empty fields show "Not found" — additional sources (Crunchbase, X, IndieHackers, Acquire.com) coming.
📝 About this app
Designed for pediatric intensivists, DrugDoses provides precise and up-to-date medication information to ensure the safety and recovery of your patients. With over 2,150 drug entries, it’s a comprehensive resource for commonly prescribed drugs for both adults and children.
Frank Shann’s DrugDoses booklet has been a trusted tool for nearly 40 years. The iOS version keeps you at the forefront of therapeutic advancements, updating drug information faster than the paper version.… View full description on the official store →
Frank Shann’s DrugDoses booklet has been a trusted tool for nearly 40 years. The iOS version keeps you at the forefront of therapeutic advancements, updating drug information faster than the paper version.… View full description on the official store →
App Specs
🔐 Own this app? Claim & verify MRR →💾 21 MB🔞 17+📱 iOS 12.0+🔖 v6.7.2🔄 updated 0d ago🌐 EN📂 Education💰 Paid
📅
What Worked™ · Development Pipeline
7 EVENTS TRACKEDDetected changes in this app over its tracked lifetime — each event links cause (what changed) to effect (what moved). Sorted newest first.See full history →Version history →
2026-05
⭐
Rating ↓ 4.90 → 4.60 (dropped 0.30★)
2026-05
💲
Went paid — introduced $14.99 price point
2026-03
⭐
Rating ↑ 2.17 → 4.90 (improved 2.73★)
2026-03
📈
Crossed 10 ratings — social-proof flywheel kicking in
2014-12
⭐
Rating ↓ 3.00 → 2.33 (dropped 0.67★)
2014-10
⭐
Rating ↓ 5.00 → 3.00 (dropped 2.00★)
2012-03
🚀
First tracked snapshot — initial data captured
🌍
Multi-Country Performance
Available in 6 of 9 monitored markets| Market | Rating | Reviews | Current version |
|---|---|---|---|
| 🇺🇸 US | 4.59999★ | 35 | 4.59999★ this version |
| 🇩🇪 DE | 4.85401★ | 137 | 4.85401★ this version |
| 🇯🇵 JP | 3.83333★ | 6 | 3.83333★ this version |
| 🇦🇺 AU | 4.83531★ | 674 | 4.83531★ this version |
| 🇧🇷 BR | 3★ | 2 | 3★ this version |
| 🇮🇳 IN | 4.86538★ | 52 | 4.86538★ this version |
🔔
Track this app’s revenue
FREEGet an email when revenue moves by your threshold. No spam, unsubscribe in one click.
📝 Description
95
BU Score · Transcendent
About this analysis
Why low confidence: only 35 ratings · no founder-verified revenue (model estimate only) · revenue figure is directional only.
❓ Frequently Asked Questions
4 answers · auto-generated from this app's public dataHow much does DrugDoses make per month?▴
Based on our ML-calibrated revenue forecast, DrugDoses earns approximately $9.3K/mo. This is a US-storefront-equivalent estimate; global revenue can be several times larger for internationally-distributed apps. See the methodology page for the full formula and confidence bands.
What apps are like DrugDoses?▴
Browse the full Education category catalog to find similar apps with revenue, build cost, audience and tech stack data. Each /p/{slug} page also shows a Compare side-by-side widget with three peer apps from the same niche.
Who makes DrugDoses?▴
DrugDoses is published by Oliver Karam on the Apple App Store. See the full publisher portfolio (other apps by the same developer) via the More by developer block on the product page above.
What is DrugDoses's BU Score?▴
DrugDoses has a BU Score of 59/100 (Solid). The score combines App Store rating, ratings count, monetization model and revenue signals calibrated against founder-verified MRR anchors. See the BU Score formula.